This response reaffirms the authors' position that intensive blood pressure lowering is beneficial in SPRINT-eligible ACCORD-BP participants, despite discordant overall trial results.
Drs. Mi and Mukamal (1) have recently proposed an additional interpretation of the discrepant results of the Systolic Blood Pressure Intervention Trial (SPRINT) and the Action to Control Cardiovascular Risk in Diabetes Blood Pressure (ACCORD-BP) trial. Although we continue to support our conclusions that SPRINT-eligible ACCORD-BP participants benefited from intensive blood pressure lowering, we recognize that our results do not exclude the important contributions from other factors as explanations for the discrepant results of ACCORD-BP and SPRINT (2). Indeed, several alternative hypotheses have been proposed in an attempt to explain the discordant results of SPRINT and ACCORD-BP (3,4). We therefore welcome the contributions by Mi …
No takes yet. Share an insight, caveat, or question.
Buckley et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: